These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 10767071)

  • 21. [Iron-oxide-enhanced MR imaging of inflammatory atherosclerotic lesions: overview of experimental and initial clinical results].
    Schmitz SA
    Rofo; 2003 Apr; 175(4):469-76. PubMed ID: 12677500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA; Saokar A; Harisinghani MG
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution and toxicity of MR imaging contrast media.
    Oksendal AN; Hals PA
    J Magn Reson Imaging; 1993; 3(1):157-65. PubMed ID: 8428083
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of approved MR contrast media for intravenous injection.
    Runge VM
    J Magn Reson Imaging; 2000 Aug; 12(2):205-13. PubMed ID: 10931582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast agents for magnetic resonance imaging: safety update.
    Kirchin MA; Runge VM
    Top Magn Reson Imaging; 2003 Oct; 14(5):426-35. PubMed ID: 14625469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of MR liver specific contrast media.
    Bellin MF; Webb JA; Van Der Molen AJ; Thomsen HS; Morcos SK;
    Eur Radiol; 2005 Aug; 15(8):1607-14. PubMed ID: 15627176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR contrast agents in acute experimental cerebral ischemia: potential adverse impacts on neurologic outcome and infarction size.
    Doerfler A; Engelhorn T; Heiland S; Knauth M; Wanke I; Forsting M
    J Magn Reson Imaging; 2000 Apr; 11(4):418-24. PubMed ID: 10767071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic physics of MR contrast agents and maximization of image contrast.
    Hendrick RE; Haacke EM
    J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
    Neuwelt EA; Hamilton BE; Varallyay CG; Rooney WR; Edelman RD; Jacobs PM; Watnick SG
    Kidney Int; 2009 Mar; 75(5):465-74. PubMed ID: 18843256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.
    Corot C; Petry KG; Trivedi R; Saleh A; Jonkmanns C; Le Bas JF; Blezer E; Rausch M; Brochet B; Foster-Gareau P; Balériaux D; Gaillard S; Dousset V
    Invest Radiol; 2004 Oct; 39(10):619-25. PubMed ID: 15377941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The endorem tolerance profile].
    Laniado M; Chachuat A
    Radiologe; 1995 Nov; 35(11 Suppl 2):S266-70. PubMed ID: 8588033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.